日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Refining prognostic tools in Waldenström macroglobulinemia

改进华氏巨球蛋白血症的预后工具

Lionel, Anath C; Thomas, Sheeba K

The Association of a Positive Fecal Immunochemical Test With the Risk of Gastroesophageal Cancer: An Age-Sex-H. Pylori Exposure Matched Cohort Study and Cost-Effectiveness Analysis

粪便免疫化学检测阳性与胃食管癌风险的关联:一项按年龄、性别和幽门螺杆菌感染情况匹配的队列研究及成本效益分析

Levi, Zohar; Abu-Freha, Naim; Boltin, Doron; Golan, Maya Aharoni; Konikoff, Tom; Arbib, Orly Sneh; Belfer, Rachel Gingold; Eizenstein, Sapir; Vilkin, Alex; Kusnir, Shiri; Turgeman, Adi; Babich, Tanya; Leshno, Moshe; Flugelman, Anath A; Edelman-Klapper, Hadar; Half-Onn, Elizabeth

Validation of a Diabetes Subtype Classification Model Using Data from U.S. Adults Before and After the COVID-19 Pandemic

利用美国成年人在新冠疫情前后的数据验证糖尿病亚型分类模型

Lu, Brian; Li, Peng; Crouse, Andrew B; Grimes, Tiffany; Smith, Ava N; Might, Matthew; Ovalle, Fernando; Shalev, Anath

Germline determinants of toxicity and efficacy in patients with large B-cell lymphoma treated with CAR T-cell therapy

CAR-T细胞疗法治疗大B细胞淋巴瘤患者的毒性和疗效的种系决定因素

Strati, Paolo; Brandt, Amanda; Lionel, Anath C; Henderson, Jared; Westin, Jason R; Adkins, Sherry; Shpall, Elizabeth J; Kebriaei, Partow; Ramdial, Jeremy; Saini, Neeraj; Ahmed, Sairah; Flowers, Christopher; Neelapu, Sattva S; Hildebrandt, Michelle A T

Cytokine Storms in COVID-19, Hemophagocytic Lymphohistiocytosis, and CAR-T Therapy

COVID-19、噬血细胞性淋巴组织细胞增生症和CAR-T疗法中的细胞因子风暴

Long, James P; Prakash, Rishab; Edelkamp, Paul Jr; Knafl, Mark; Lionel, Anath C; Nair, Ranjit; Ahmed, Sairah; Strati, Paolo; Castillo, Luis E Malpica; Al-Zaki, Ajlan; Chien, Kelly; Chihara, Dai; Westin, Jason; Khawaja, Fareed; Nastoupil, Loretta J; Mulanovich, Victor; Futreal, Andrew; Woodman, Scott E; Daver, Naval G; Flowers, Christopher R; Neelapu, Sattva; Manzano, Joanna-Grace; Iyer, Swaminathan P

Treatment and outcomes of progression of disease post-CAR T-cell therapy in mantle cell lymphoma: a multicenter analysis

套细胞淋巴瘤CAR-T细胞疗法后疾病进展的治疗及预后:一项多中心分析

Epstein-Peterson, Zachary D; Lionel, Anath C; Joseph, Ashlee; Drill, Esther; Atallah-Yunes, Suheil Albert; Brooks, Taylor R; Chong, Elise A; Chong, Emeline R; Dela Cruz, Jamie; Frank, Matthew J; Ip, Andrew; Iqbal, Madiha; Jacobson, Caron A; Kamdar, Manali K; Karmali, Reem; Beyar-Katz, Ofrat; Maddocks, Kami J; Matasar, Matthew J; McLoughlin, Daniel; Merryman, Reid W; Munoz, Javier L; Navalekar, Rohini; Rhodes, Joanna; Riedell, Peter A; Ryan, Christine E; Salles, Gilles; Sauter, Craig S; Sawalha, Yazeed; Sharma, Samanvaya; Shouval, Roni; Shukla, Navika; Therwhanger, Dylan; van Besien, Herman; Varon, Ben; Wang, Yucai; Yamshon, Samuel; Zelenetz, Andrew D; Palomba, Maria Lia; Jain, Preetesh; Kumar, Anita

Oral TIX100 protects against obesity-associated glucose intolerance and diet-induced adiposity.

口服 TIX100 可预防肥胖相关的葡萄糖耐受不良和饮食引起的脂肪堆积

Jo SeongHo, Jing Gu, Chen Junqin, Xu Guanlan, Shalev Anath

Data-driven Cluster Analysis Reveals Increased Risk for Severe Insulin-deficient Diabetes in Black/African Americans

数据驱动的聚类分析揭示黑人/非裔美国人患严重胰岛素缺乏型糖尿病的风险增加

Lu, Brian; Li, Peng; Crouse, Andrew B; Grimes, Tiffany; Might, Matthew; Ovalle, Fernando; Shalev, Anath

Extensive biofilm covering on sgraffito wall art: a call for proactive monitoring

刮画墙面上大面积生物膜覆盖:呼吁开展主动监测

Nir, Irit; Sharaby, Anath; Barak, Hana; Pavan, Mariela J; Friedlander, Lonia R; Multanen, Victor; Kushmaro, Ariel

Target Discovery to Diabetes Therapy-TXNIP From Bench to Bedside With NIDDK

从靶点发现到糖尿病治疗——TXNIP从实验室到临床(NIDDK项目)

Shalev, Anath